RHY rhythm biosciences limited

Board Re-Structure

  1. 383 Posts.
    lightbulb Created with Sketch. 121
    I must say, the Board is looking extremely well credentialed since the much-needed re-structure. New CEO David Atkins is extremely well-connected, which is evident in the recent appointment of Gavin Fox-Smith as Non-Executive Director.

    Gavin Fox-Smith BSc, MBA, GAICD
    His career spans over 35 years, previously holding the position of Managing Director Australia/NZ and Vice President Asia Pacific for Johnson & Johnson Medical Devices, Chair of the Medical Technology Association of Australia, Governor of American Chamber of Commerce, Co-Founder/Chair of Macquarie Park Business Coalition (in partnership with United Way) and Australian Co-Chair of the Health Technology Sector Group of the Australia/NZ Leadership Forum.
    Gavin is currently transitioning out of his executive CEO role at Omnigon, a private Australian company in the Ostomy Care market. He is at this time, Chair of ANDHealth (Australia’s National Digital Health Initiative), Board Director for Bowel Cancer Australia and Board Director for SAN Foundation. Gavin is a proud member of the Champions of Change Coalition STEM/Health group and serves as Ambassador for Rotary Oceania Medical Aid for Children (ROMAC). Gavin is a Graduate of the Australian Institute of Company Directors and recently completed the AICD Boardroom Mastery program.

    Dr David Atkins, Rhythm CEO & Managing Director
    Over the last 30 years, David has held national, regional and global roles across the pharmaceutical, medical device and diagnostics sectors. David’s responsibilities have covered all functions from discovery research through to sales and marketing in most key geographies. He has valuable experience in start-up ventures, scale-ups, turnarounds and high-growth enterprises. He has held senior leadership roles in smaller businesses including Congenica (UK), Veridex (US) and Gene Shears (Australia), and larger global businesses including Johnson & Johnson and Danaher.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
10.5¢
Change
-0.005(4.55%)
Mkt cap ! $29.82M
Open High Low Value Volume
10.5¢ 11.0¢ 9.9¢ $235.5K 2.274M

Buyers (Bids)

No. Vol. Price($)
2 66620 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 251207 3
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.